- Have any question?
- +995599096730
- neurogeorgia@gmail.com
The Parkinson’s & Movement Disorders group at the International Center for Neuroscience Research focuses on a spectrum of movement disorders that present with symptoms varying from subtle manifestations to severely disabling conditions. Our specialists provide research using cutting-edge diagnostic tools and state-of-the-art treatments tailored to each patient’s unique needs. Patients have opportunities to participate in various research studies that enhance our understanding of these complex conditions. In collaboration with other research institutions, we conduct ongoing pharmacotherapy trials that offer patients access to novel therapeutics not yet widely available.
The Parkinson’s & Movement Disorders group strives to deepen our understanding of these conditions by investigating biological causes and developing innovative treatments. We recognize that continuous clinical research is essential to achieving meaningful progress in this field. What distinguishes our center is the on-site collaboration among clinician specialists from diverse disciplines, bringing varied expertise and perspectives to our clinical research initiatives and patient care approaches.
Our mission centers on advancing research in the field of movement disorders. We emphasize rigorous clinical research that explores new medical and surgical treatment options. The knowledge generated through our research directly enhances our ability to deliver cutting-edge care, positions us as international group in movement disorder management, and enables us to educate the next generation of medical professionals. We conduct numerous clinical trials in our continuous effort to develop superior treatments. We prioritize developing medications that can slow or halt Parkinson’s disease progression.
We work to enhance understanding of both motor and non-motor symptoms that affect patients with these conditions.
Our teams investigate the underlying causes and mechanisms that lead to the development of Parkinson's and related disorders.
We focus on refining existing treatments and developing new symptomatic and biological interventions that can improve quality of life for those affected by movement disorders.
Dr. Nasrollah Moradikor, Ph.D., is currently Principal Investigator and Head of Brain Aging and Dementia at the International Center for Neuroscience Research in Georgia. Dr. Nasrollah has demonstrated exceptional leadership skills in promoting applied neuroscience research and establishing fruitful collaborations among scientists worldwide. In 2021, Dr. Nasrollah founded a new community platform named “Neuroscience Network” to support and develop neuroscience in the world. His ability to create a supportive and intellectually stimulating environment has been instrumental in promoting the development of aspiring neuroscientists. He has over 15 years of research and teaching experience and till now he has chaired many national and international events in the area of neuroscience. Nasrollah has been on the scientific advisory board and evaluation committees of several institutions abroad.
Collaborating Faculty
Collaborating Faculty
Collaborating Faculty
Affiliated Researcher
Affiliated Researcher
Affiliated Researcher
Affiliated Researcher
Professor International Islamic University Malaysia, Malaysia
Professor Osaka University, Japan
Professor University of Leeds, UK
Professor Ilia State University, Georgia
Professor Alalamein International University, Egypt
Professor Pasteur Institute of Tunisia, Tunisia
The Parkinson’s and Movement Disorders group Grants program fuels translational research that promises to revolutionize clinical care for movement disorder patients. We provide financial support for promising research projects characterized by collaboration, significant impact potential, and likelihood of attracting subsequent funding. Our grants fund basic, translational, and clinical research on Parkinson’s and related conditions, including Parkinson’s disease, Atypical parkinsonism, Essential tremor, Lewy Body Dementia, Huntington Disease, Dystonia, Tourette syndrome/Tic Disorders, Ataxia,Tardive dyskinesia, Sleep Disorders in Movement Disorders and Restless leg syndrome.
We support a wide range of therapeutic research, from basic studies of disease mechanisms to early-stage clinical trials, including innovative approaches that repurpose existing medications. Research without clear therapeutic applications falls outside our funding priorities.
If you have questions about the group, please contact us
